MAbs, B-cells (Tanox Biosystems)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMAbs, B-cells (Tanox Biosystems)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, Non-HodgkinLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanox Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanox Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesLymphoma, Non-HodgkinLeukemia

Other Information

ATC CodeN/A
Related LinksN/A